Norbrook Laboratories is one of the world's largest independent manufacturers of veterinary pharmaceuticals, producing a broad portfolio of licensed medicines supplied to more than 120 countries from its manufacturing base in Newry, Northern Ireland.
Founded in 1969 by Dr Edward Haughey, Norbrook has grown from a regional supplier into a globally recognised name in animal health, with a product range spanning injectable solutions, oral liquids, tablets, premixes, and topical treatments. The company serves both companion animal and food-producing animal markets, with particular strength in cattle, sheep, pigs, and poultry segments.
Its manufacturing facilities in Newry are among the most extensively licensed in the veterinary sector, holding regulatory approvals from agencies including the UK Veterinary Medicines Directorate, the US Food and Drug Administration, and the European Medicines Agency. This multi-market approval status allows Norbrook to supply generic and branded veterinary medicines to customers across Europe, North America, Australasia, and beyond.
The company operates its own research and development programme, enabling it to bring new veterinary formulations to market and expand its therapeutic portfolio. Core areas include antibiotics, anti-inflammatories, antiparasitic treatments, and reproductive medicines for livestock and companion animals.
Norbrook remains privately held and headquartered in Northern Ireland, a notable distinction given the scale of its international distribution footprint. It employs several thousand people across its Newry sites and international offices, making it one of the largest private employers in the region.
Further information is available at norbrook.com.